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Cholesterol is an essential constituent of eukaryotic membranes and plays a crucial role in membrane organization, dynamics, function, and
sorting. It is often found distributed non-randomly in domains or pools in biological and model membranes and is thought to contribute to a
segregated distribution of membrane constituents. Signal transduction events mediated by seven transmembrane domain G-protein coupled
receptors (GPCRs) are the primary means by which cells communicate with and respond to their external environment. We analyzed the role of
cholesterol in the plasma membrane organization of the G-protein coupled serotonin1A receptor by fluorescence recovery after photobleaching
(FRAP) measurements with varying bleach spot sizes. Our results show that lateral diffusion parameters of serotonin1A receptors in normal cells
are consistent with models describing diffusion of molecules in a homogenous membrane. Interestingly, these characteristics are altered in
cholesterol-depleted cells in a manner that is consistent with dynamic confinement of serotonin1A receptors in the plasma membrane. Importantly,
analysis of ligand binding and downstream signaling of the serotonin1A receptor suggests that receptor function is affected in a significantly
different manner when intact cells or isolated membranes are depleted of cholesterol. These results assume significance in the context of
interpreting effects of cholesterol depletion on diffusion characteristics of membrane proteins in particular, and cholesterol-dependent cellular
processes in general.
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Cholesterol is an essential constituent of eukaryotic
membranes and plays a crucial role in membrane organization,
dynamics, function, and sorting [1,2]. It is often found
distributed non-randomly in domains or pools in biological
and model membranes and is thought to contribute to a
segregated distribution of membrane constituents [1–3].
Cholesterol is proposed to maintain a laterally heterogeneous
distribution of lipids and proteins on the plasma membrane dueAbbreviations: 8-OH-DPAT, 8-hydroxy-2(di-N-propylamino)tetralin; EYFP,
enhanced yellow fluorescent protein; FRAP, fluorescence recovery after
photobleaching; GPCR, G-protein coupled receptor; IBMX, 3-isobutyl-1-
methylxanthine; MβCD, methyl-β-cyclodextrin
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doi:10.1016/j.bbamem.2007.01.002to its putative role in the formation and maintenance of domains
such as lipid rafts [4]. Removal of cholesterol from cell
membranes is reported to disrupt the integrity of these domains
[5], and therefore represents a widely used strategy to disrupt
putative functions mediated by these domains. This forms the
basis of a number of reports implicating such domains in
important cellular functions such as signal transduction [6], and
entry of pathogens [7].
Seven transmembrane domain G-protein coupled receptors
(GPCRs) constitute one of the largest family of proteins in
mammals and account for ∼2% of the total proteins coded by
the human genome [8]. Signal transduction events mediated by
GPCRs are the primary means by which cells communicate
with and respond to their external environment [9]. As a
consequence, GPCRs represent major targets for the develop-
ment of novel drug candidates in all clinical areas [10]. The
major paradigm in GPCR signaling is that their stimulation
leads to the recruitment and activation of heterotrimeric GTP-
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are fundamental to all types of GPCR signaling, occur at the
plasma membrane via protein–protein interactions. An impor-
tant consequence is that the organization of molecules such as
receptors and G-proteins in the membrane represents an
important determinant in GPCR signaling [12,13]. In this
regard, the observation that GPCRs are not uniformly present on
the plasma membrane but are concentrated in specific
membrane domains that are enriched in cholesterol assumes
significance [12]. The segregated distribution of GPCRs has
given rise to new challenges and complexities in receptor
signaling since signaling now has to be understood in context of
the two dimensional organization of various signaling compo-
nents, which include receptors and G-proteins, in the plane of
the membrane. The G-protein coupled serotonin1A receptor is
the most extensively studied among the serotonin receptors due
to the early availability of a selective ligand 8-OH-DPAT that
allows extensive biochemical, physiological, and pharmacolo-
gical characterization of the receptor [14,15]. The functional
significance of the serotonin1A receptor is evident from the
phenotype exhibited by the mutant (knockout) mice lacking the
receptor [16–18]. These mice exhibit enhanced anxiety-related
behavior and represent important animal models for the analysis
of complex traits such as anxiety disorders and aggression in
higher organisms [19].
In this paper, we monitored the membrane organization of
the serotonin1A receptor by analyzing its lateral diffusion
parameters in the plasma membrane of living cells using the
fluorescence recovery after photobleaching (FRAP) approach.
In light of the significance of cholesterol in the organization and
function of membrane proteins in general, and GPCRs in
particular [12,13], we monitored the effect of specific depletion
of cholesterol on the lateral diffusion parameters of the
serotonin1A receptor. Furthermore, we analyzed ligand binding
and downstream signaling of the serotonin1A receptor in normal
and cholesterol-depleted cells in order to comprehensively
understand the functional significance of the membrane
organization of serotonin1A receptors.
2. Materials and methods
2.1. Materials
MβCD, 8-OH-DPAT, penicillin, streptomycin and gentamycin sulfate were
obtained from Sigma (St. Louis, MO). D-MEM/F-12 (Dulbecco's Modified
Eagle Medium: nutrient mixture F-12 (Ham) (1:1)), fetal calf serum, and
geneticin (G 418) were from Invitrogen Life Technologies (Carlsbad, CA).
Forskolin and IBMXwere from Calbiochem (San Diego, CA). [3H]8-OH-DPAT
(sp. activity=135.0 Ci/mmol) was from DuPont New England Nuclear (Boston,
MA). Amplex Red cholesterol assay kit was from Molecular Probes (Eugene,
OR). Cyclic AMP [3H] assay kit was from Amersham Biosciences
(Buckinghamshire, UK).
2.2. Methods
2.2.1. Cells and cell culture
Chinese hamster ovary (CHO) cells stably expressing the human serotonin1A
receptor and the receptor tagged to EYFP (serotonin1A-EYFP receptor) were
grown in D-MEM/F-12 (1:1) supplemented with 2.4 g/l of sodium bicarbonate,
10% fetal calf serum, 60 μg/ml penicillin, 50 μg/ml streptomycin, 50 μg/mlgentamycin sulfate and 200–300 μg/ml geneticin in a humidified atmosphere
with 5% CO2 at 37 °C. Importantly, the serotonin1A receptor and its tagged form
expressed in these cells have been found to be essentially similar to the native
serotonin1A receptor expressed in bovine hippocampus in terms of their
pharmacology and cellular signaling characteristics [20,21].
2.2.2. Cholesterol depletion of cells in culture
Cells plated at a density of 5×105 in 100 mm petridishes were grown for
3 days followed by incubation in serum-free D-MEM/F-12 (1:1) medium for
3 h. Cholesterol depletion was carried out by treating cells with increasing
concentrations of MβCD in serum-free D-MEM/F-12 (1:1) medium for 30 min
at 37 °C followed by a wash with serum-free D-MEM/F-12 (1:1) medium.
2.2.3. Cholesterol depletion of isolated cell membranes
Cell membranes were isolated by differential centrifugation as described
previously [20]. Cell membranes suspended at 1 mg/ml protein concentration
were depleted of cholesterol with varying concentrations of MβCD in 50 mM
Tris, pH 7.4 buffer at 24 °C with constant shaking for 30 min [22]. Membranes
were then spun down at 40,000×g for 5 min at 4 °C, washed and suspended in
50 mM Tris, pH 7.4 buffer.
2.2.4. Analysis of cholesterol and phospholipid contents
Cholesterol content in cell membranes was estimated using the Amplex Red
cholesterol assay kit [23]. Total phospholipid content in these membranes was
determined subsequent to digestion with perchloric acid as described earlier
[24].
2.2.5. Radioligand binding assays
Receptor binding assay with the radiolabeled agonist [3H]8-OH-DPAT (final
concentration=0.29 nM) was carried out as described previously [20,21].
Saturation binding data were analyzed to estimate the equilibrium dissociation
constant (Kd) and maximum binding sites (Bmax) using the Graphpad Prism
software version 4.00 (San Diego, CA).
2.2.6. Cellular signaling assay
Cells plated at a density of 1×104 per well of a 24-well plate were grown for
3 days followed by incubation in serum-free D-MEM/F-12 (1:1) medium for
3 h. Cells were then exposed to serum-free D-MEM/F-12 (1:1) medium
containing 10 μM forskolin, 50 μM of the phosphodiesterase inhibitor IBMX,
and a range (10−12 to 10−5 M) of concentrations of 8-OH-DPAT at 37 °C for
30 min. The assay was terminated by hypotonic lysis of cells with 10 mM Tris,
5 mM EDTA, pH 7.4 buffer. Cell lysates were boiled for 3 min, brought to room
temperature, and spun at 40,000×g for 10 min at 4 °C to remove precipitated
protein. Amount of cAMP in an aliquot of the supernatant was estimated using
the Cyclic AMP [3H] assay kit that is based on the protein-binding method [25].
2.2.7. Confocal microscopy and fluorescence recovery after photobleaching
(FRAP)
Confocal imaging was carried out on an inverted Zeiss LSM 510 Meta
confocal microscope with a Plan-Apochromat 63×, 1.2 NA water-immersion
objective using the 514 nm line of an argon laser. Fluorescence emission was
collected using the 535–590 nm bandpass filter with the confocal pinhole set
between 1 and 2 airy units. Fluorescence distribution analysis of serotonin1A-
EYFP receptors in response to cholesterol depletion was carried out by imaging
the same field of cells before and after treatment with 10 mMMβCD for 30 min
in PBS containing Ca2+ and Mg2+ in an FCS2 closed temperature controlled
Bioptechs chamber (Butler, PA) maintained at 37 °C. Fluorescence intensity
profiles across a line identically positioned in images acquired before and after
cholesterol depletion were analyzed using the Zeiss LSM 510 software (version
3.2). FRAP measurements were performed on cells maintained at 37 °C in PBS
containing Ca2+ and Mg2+ under conditions described previously [21], with a
few modifications. The fluorescent periphery of cells that represents the plasma
membrane was selected for bleaching and monitoring recovery of fluorescence.
The data on diffusion coefficient (D) and mobile fraction (Mf) were calculated
from quantitative FRAP experiments where just the bleached region was
scanned to achieve improved temporal resolution. The dimensions of the bleach
spot were varied by performing FRAP experiments with circular ROIs of
different radii. Importantly, recovery of fluorescence intensity was only
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entire circular ROI placed across the cell periphery was bleached in FRAP
experiments. The bleach time point was calculated as the mid-point of the bleach
duration. This resulted in the first post-bleach time point starting from a time t
>0. Data representing the mean fluorescence intensity in the membrane region
(obtained using the Zeiss LSM 510 software, version 3.2) within the bleached
spot were corrected for background and analyzed. For a two-dimension
diffusion model, FRAP data were fit to determine the characteristic diffusion
time (τd) [26]:
FðtÞ ¼ ½FðlÞ  Fð0Þ½expð2sd=tÞðI0ð2sd=tÞ þ I1ð2sd=tÞÞ þ Fð0Þ ð1Þ
where F(t) is the mean background-corrected and normalized fluorescence
intensity at time t in the membrane region within the bleached spot, F(∞) is the
recovered fluorescence at time t→∞, and F(0) is the bleached fluorescence
intensity at time t→0. I0 and I1 are modified Bessel functions. The effective
two-dimensional diffusion coefficient (D2D) is determined from the equation:
D2D ¼ x2=4sd ð2Þ
whereω is the radius of the bleached spot. For a one-dimension diffusion model,
FRAP data were fit to determine the effective one-dimensional diffusion
coefficient (D1D) [27]:
FðtÞ ¼ FðlÞ½1 ðx2ðx2 þ 4pD1DtÞ1Þ1=2 ð3Þ
where ω is the width of the bleach spot. As described earlier [28], F(0) was
subtracted from F(t) before FRAP data was fit to Eq. (3). Mobile fraction (Mf) is
calculated according to the equation:
Mf ¼ ½FðlÞ  Fð0Þ=½FðpÞ  Fð0Þ ð4Þ
where F(p) is the mean background-corrected and normalized pre-bleach
fluorescence intensity. Non-linear curve fitting of fluorescence recovery data
to Eqs. (1) and (3) was carried out using the Graphpad Prism software
version 4.00 (San Diego, CA). For representation purposes, post-bleach
fluorescence intensities in FRAP recovery plots were normalized according
to [F(t)−F(0)] / [F(p)−F(0)].3. Results
3.1. Organization of membrane constituents monitored using
FRAP
Monitoring lateral diffusion of molecules in the membrane
represents a powerful approach to understand their membrane
organization [29,30]. FRAP is a widely used approach to
quantitatively estimate diffusion properties of molecules. This
approach provides information on the diffusion behavior of an
ensemble of molecules, as the area monitored is large (in the
order of micrometers) [30,31]. Since fluorescence recovery
kinetics in FRAP measurements contains information on the
area being monitored, a comprehensive understanding of the
spatial organization of molecules in the plasma membrane can
be obtained by systematically varying the area monitored in
FRAP experiments [31]. Deviations in diffusion characteristics
of molecules obtained from FRAP experiments performed with
bleach spots of different sizes have been correlated to the
presence of domains on the cell surface with dimensions that
fall in the same range as the area monitored in these experiments
[32–35]. This interpretation is based on the model described
below, and has been previously validated by molecular
dynamics simulations and FRAP experiments performed on
physically domainized model membrane systems [34]. It mustbe mentioned here that the domains detected by FRAP
performed at variable bleach spot sizes must not be confused
with domains such as lipid rafts that are currently believed to
exist as lateral heterogeneities in the membrane on a
spatiotemporal scale far lower than the resolution of FRAP
measurements [30].
The recovery of fluorescence into the bleached spot in FRAP
experiments is described by two parameters, an apparent
diffusion coefficient (D) and mobile fraction (Mf). The rate of
fluorescence recovery provides an estimate of the apparent D of
molecules, while the extent to which fluorescence recovers
provides an estimate ofMf of molecules. Importantly,Mf is only
an estimate of the fraction of molecules mobile at the time scale
of the FRAP experiment. In general, for molecules diffusing
laterally in a homogenous membrane, the diffusion coefficient
(D) is independent of the dimensions of the bleach spot in
FRAP measurements. A small bleach spot (Fig. 1A) results in
faster fluorescence recovery while a large bleach spot (Fig. 1B)
results in slower fluorescence recovery, effectively providing a
constant value of D. Moreover, if the bleached area is
significantly smaller than the total area of the membrane, the
extent of fluorescence recovery is the same in both cases
resulting in a constant mobile fraction (Mf).
In contrast, if diffusion were confined to closed domains of
dimensions that are of the same scale as that of the bleach spot,
and static in the time scale of FRAP experiments, D would no
longer be a constant. A small bleach spot (Fig. 1C) would tend
to monitor diffusion properties of molecules within domains.
Thus, kinetics of fluorescence recovery with a small bleach spot
on a domainized membrane would be similar to that seen on a
homogenous membrane (assuming that the intrinsic membrane
properties are similar in the homogenous or domainized state).
However, a large bleach spot (overlapping different domains to
varying extents, Fig. 1D) would result in non-uniform bleaching
of domains since the bleached area would be partial for a few
and complete for others. As a consequence, kinetics of
fluorescence recovery in the entire region of observation
would not be proportional to the actual size of the bleach
spot. While kinetics of fluorescence recovery within domains
would be proportional to the area bleached in these domains, the
apparent D would show an increase (since D is calculated
taking into account the actual bleach spot size). Importantly, a
large bleach spot would reduce the Mf since it could bleach an
entire domain resulting in total loss of fluorescence in such a
domain (Fig. 1D).
3.2. Cellular distribution of serotonin1A receptors in normal
and cholesterol-depleted cells
We monitored the lateral diffusion properties of the G-
protein coupled serotonin1A receptor in the plasma membrane
of living cells using such a FRAP approach to detect any
possible domain organization and the role of cholesterol in
such organization of the receptor. Cholesterol depletion has
earlier been reported to affect cellular sorting [36], distribution
[37], endocytosis [38] and trafficking [39] of membrane
proteins. As a control, we therefore analyzed if the cellular
Fig. 1. Possible outcomes of FRAP performed on a homogenous (A and B) and domainized (C and D) membrane with a small (as in panels A and C) or a large (B and
D) bleach spot are shown. The circle indicates the region of observation and bleach. Fluorescence recovery kinetics for a small (A) or a large (B) bleach spot on a
homogenous membrane is proportional to the size of the spot. Smaller bleach spots result in faster kinetics of fluorescence recovery leading to a constant diffusion
coefficient. In addition, if the bleach area is significantly smaller than the total area of the membrane, the extent of fluorescence recovery is the same in both cases
resulting in a constant mobile fraction. FRAP measurements on a homogenous membrane therefore show a constant diffusion coefficient and mobile fraction with
increasing bleach spot size. In contrast, if diffusion of molecules is confined to closed membrane domains which are static in the time scale of FRAP experiments, the
rate of fluorescence recovery for a small (C) or a large (D) bleach spot is no longer proportional to the size of the bleach spot. In this case, florescence recovery kinetics
for a small or large bleach spot would be dependent on the area bleached within the domains. This results in an apparent diffusion coefficient that varies with the size of
the bleach spot. Larger bleach spots would tend to overestimate the diffusion coefficient since fluorescence recovery kinetics (observed only from diffusion within
domains) would be disproportionate to the area bleached. In addition, a large bleach spot (panel D) would reduce the mobile fraction since it would bleach an entire
domain resulting in total loss of fluorescence in such a domain. FRAP measurements on such a domainized membrane therefore show an increase in diffusion
coefficient and decrease in mobile fraction with increasing bleach spot size. See text for further details.
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alterations in cellular cholesterol levels by comparing the
fluorescence distribution of serotonin1A-EYFP receptors in
normal and cholesterol-depleted cells. Cells were depleted of
cholesterol using MβCD, a water soluble compound that has
previously been shown to selectively extract cholesterol from
the plasma membrane by including it in a central non-polar
cavity [13]. Confocal mid-plane sections of cells stably
expressing serotonin1A-EYFP receptors display typical plasma
membrane localization characterized by higher fluorescence
intensity at the cell periphery (Fig. 2A). The fluorescence
distribution in the same group of cells when imaged after
cholesterol depletion (using 10 mM MβCD for 30 min at
37 °C), shows no significant differences (Fig. 2B), and is
apparent from the similarity in line-profiles of the fluorescence
distribution of serotonin1A-EYFP receptors in the same group
of cells before and after depletion of cholesterol (Fig. 2C and
D). Importantly, the mean background-corrected fluorescence
intensities at the cell periphery obtained from a large numberof unbiased quantitative measurements on normal and
cholesterol-depleted cells appear to be similar (Fig. 2E).
These results show that cholesterol depletion does not induce
any significant alteration in cellular distribution of serotonin1A-
EYFP receptors in metabolically active cells. Quantitative
analysis of the extent of cholesterol depletion upon treatment
of cells with increasing concentrations of MβCD is shown in
Fig. 2F. Thus, treatment of cells with 10 mM MβCD reduces
the cellular cholesterol content by ∼41%. The membrane
phospholipid content remains unaltered after such treatment
thereby indicating the specificity of cholesterol depletion
mediated by MβCD under the present conditions. Further,
the cholesterol content in cells treated with 10 mM MβCD and
maintained in serum-free medium remained ∼60% of that in
normal cells for a period of 2 h (data not shown). This indicates
that within this time frame, analysis of serotonin1A receptor
dynamics and function (see later) is not complicated by any
significant alteration in the cholesterol content due to cellular
biosynthesis. Taken together, these results set up the back-
Fig. 2. Confocal micrographs of the same group of cells expressing the serotonin1A-EYFP receptor were acquired (A) before and (B) after treatment with 10 mM
MβCD for 30 min at 37 °C under identical imaging conditions. The scale bar represents 10 μm. The fluorescence intensity profile across the horizontal line drawn in
panels (A) and (B) are shown in panels (C) and (D), respectively. The background-corrected mean fluorescence intensities of serotonin1A-EYFP receptors localized in
the plasma membrane (fluorescent periphery of cells) in normal and cholesterol-depleted cells are shown in (E). Data represent the means±S.D. of fluorescence
intensities measured in 85–87 cells from independent experiments. Quantitative analysis of cholesterol (gray bars) and total phospholipid (white bars) contents assayed
in membranes isolated from cells treated with increasing concentrations of MβCD is shown in (F). Data represent the mean±S.E. of at least three independent
experiments. See Materials and methods for other details.
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EYFP receptors as they indicate that the analysis of fluores-
cence recovery is not complicated by any significant alteration
in the distribution of receptors in response to cholesterol
depletion.3.3. Membrane organization of serotonin1A-EYFP receptors
monitored using FRAP
We analyzed the plasma membrane organization of
serotonin1A-EYFP receptors in living cells maintained at 37 °C
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shows a representative experiment performed under imaging
conditions optimized to ensure no significant photobleaching of
fluorescence during time-lapse imaging. This is apparent from
the constant mean fluorescence intensity in region 2 shown in
Fig. 3B for the entire duration of the FRAP experiment. It must
be mentioned here that while the entire circular ROI was
bleached, data on the recovering fluorescence intensity with
time was recorded only from the relatively intense fluorescent
cell periphery by drawing a mask (shown as the area marked
with dotted line in region 1 in Fig. 3A). This ensured that
although fluorescence was bleached in an area larger than the
plasma membrane, the recovery of fluorescence would
predominantly reflect diffusion of serotonin1A-EYFP receptors
confined to the plasma membrane and not from intracellular
regions. The fluorescence recovery kinetics after bleach for
spot sizes of radii 1.47 and 3 μm from quantitative FRAP
experiments performed on serotonin1A-EYFP receptors are
shown in Fig. 3C and D.
Analysis of fluorescence recovery kinetics based on a two-
dimension diffusion model of serotonin1A-EYFP receptors inFig. 3. A representative FRAP experiment performed on cells expressing serotonin
membrane was selected for bleaching and monitoring recovery of fluorescence
immediately after bleach (bleach) and after recovery (post-bleach) for a qualitative F
measure fluorescence recovery after photobleaching, region 2 to detect any possible
For quantitative FRAP measurements, fluorescence intensity was only monitored fr
by the dotted line in region 1). The scale bar represents 10 μm. Data representing th
the entire duration of the FRAP experiment are shown in (B). The relatively consta
were optimized and no significant photobleaching of fluorescence during time-la
receptors with bleach spots of (C) 1.47 and (D) 3 μm radius from quantitative FRAP
data represent means±S.D. of 15–20 independently generated non-linear regression
solid lines are non-linear regression fits of the data to Eq. (1). See Materials andnormal cells with bleach spots of different sizes (radii of
1.47–3 μm) indicates a relatively constant diffusion coeffi-
cient (mean±S.D.=0.18±0.02 μm2 s−1) and mobile fraction
Mf (mean±S.D.=73±2%) (Fig. 4A and B). The relatively
constant D and Mf over a range of bleach spot sizes in normal
cells therefore suggests that serotonin1A-EYFP receptors ex-
perience a membrane environment that appears homogenous
in the spatiotemporal resolution of FRAP measurements
(based on conditions described in Fig. 1A and B). It must be
mentioned here that we have previously validated FRAP
analysis with a range of bleach spot sizes on a homogenous
model system of pure GFP in a 90% glycerol–water mixture at
25 °C [40]. The D for such a system was effectively constant
across a wide range of bleach spot sizes with an estimated mean
of 0.66 μm2 s−1 that is similar to the value of 0.7 μm2 s−1
calculated using the Stokes–Einstein equation in a medium of
viscosity corresponding to 90% glycerol–water mixture [41].
Interestingly, FRAP experiments performed on cholesterol-
depleted cells with a similar range of bleach spot sizes (1.47–
3 μm) show a marked dependence of D and Mf of serotonin1A-
EYFP receptors on the size of the bleach spot. For example,1A-EYFP receptors. The fluorescent periphery of cells representing the plasma
. Confocal images of the same group of cells before bleach (pre-bleach),
RAP experiment are shown in (A). Region 1 (radius=3 μm) was monitored to
bleaching during scanning, and region 3 to monitor background fluorescence.
om the relatively intense fluorescent cell periphery (shown as the area marked
e normalized mean fluorescence intensities from the regions depicted in (A) for
nt fluorescence intensity in region 2 in (B) shows that the imaging conditions
pse imaging took place. Fluorescence recovery kinetics of serotonin1A-EYFP
experiments are shown for normal (○) and cholesterol-depleted (●) cells. The
fits of the fluorescence recovery data to Eq. (1) for each bleach spot size. The
methods for other details.
Fig. 4. The diffusion coefficients (A, C) and mobile fractions (B, D) of serotonin1A-EYFP receptors obtained from FRAP measurements with bleach spots of different
sizes analyzed based on a two-dimension (A, B) or a one-dimension (C, D) diffusion model are shown for normal (–––○–––) and 10 mM MβCD-treated (___●___)
cells. Data represent the means±S.E. of 15–20 independent experiments for each bleach spot size. See Materials and methods for other details.
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(bleach spot radius of 1.47 μm), D in cholesterol-depleted cells
is∼1.5 fold lower than that in normal cells (Fig. 4A). In contrast,
D in cholesterol-depleted cells is ∼1.4 fold higher than that in
normal cells when the area monitored is large (radius of 3 μm,
Fig. 4A). In addition, Mf of serotonin1A-EYFP receptors in
cholesterol-depleted cells shows a progressive reduction upon
increasing the size of the bleach spot. Thus, Mf is reduced by
∼22% of its original value in response to a change in bleach spot
radius from 1.47 to 3 μm (see Fig. 4B). This type of dependence
of D and Mf of the serotonin1A-EYFP receptors in cholesterol-
depleted membranes is consistent with a model describing
confined diffusion in a domainized membrane (see Fig. 1C and
D) [32–35]. To the best of our knowledge, this is the first report
demonstrating that cholesterol depletion induces dynamic
confinement of a transmembrane protein in the plasma
membrane of living cells detected using FRAP.
We have earlier monitored the diffusion properties of
serotonin1A-EYFP receptors by performing FRAP experiments
on the surface of attached and well-spread CHO cells [21].
Based on the geometry of bleach on a homogenously
fluorescent membrane surface, data from FRAP experiments
performed in this manner can be suitably analyzed by a two-dimension diffusion model since fluorescence recovery is
expected to be laterally isotropic from all regions around the
bleached spot. However, analysis of FRAP experiments
performed in this manner on cells stably expressing fluores-
cently tagged membrane proteins can be complicated due to the
unavoidable contribution of fluorescence from intracellular
membranes. FRAP experiments performed at the cell periphery
would circumvent this problem since fluorescence at the cell
periphery would represent serotonin1A-EYFP receptors that are
predominantly localized in the plasma membrane. The
geometry of bleach at the cell periphery would however result
in fluorescence recovery being contributed largely due to
molecules diffusing across the width of the bleached spot
compared to that from above or below the plane of focus.
Fluorescence recovery data in such a case may be analyzed
based on a model assuming one-dimension diffusion [27,28]. It
must be mentioned here that fluorescence recovery kinetics for a
one-dimension diffusion process is also proportional to the
width of the bleached spot in FRAP experiments. If diffusion of
molecules is assumed to occur in a homogenous membrane, a
small or a large bleach spot would still provide a constant D.
Importantly, analysis of fluorescence recovery kinetics of
serotonin1A-EYFP receptors in normal and cholesterol-depleted
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trend as that observed with a two-dimension diffusion model.
While FRAP experiments with different bleach spot sizes on
serotonin1A-EYFP receptors in normal cells provide a relatively
constant D (mean±S.D.=0.53±0.05 μm2 s−1) and Mf (mean±
S.D.=83±3%), similar experiments in cholesterol-depleted
cells show that the D and Mf vary significantly with different
bleach spot sizes (Fig. 4C and D). Taken together, these results
indicate that the dependence of D andMf on the bleach spot size
observed for serotonin1A-EYFP receptors in cholesterol-
depleted cells is independent of the exact theoretical model
(two- or one-dimension diffusion model) used to analyze FRAP
data.
The dependence of the lateral diffusion parameters of the
serotonin1A-EYFP receptors on the bleach spot size in the
plasma membrane of cholesterol-depleted cells indicates that
cholesterol depletion leads to confined diffusion of serotonin1A-
EYFP receptors into domains. It would be interesting to
comment on the membrane environment (dynamics) in such
domains. While FRAP measurements performed with a large
bleach spot would suggest the presence or absence of confined
diffusion in domains, measurements performed with a small
bleach spot would provide information on the lateral diffusion
properties of molecules on a local (relatively short) scale either
on a homogenous (Fig. 1A) or domainized membrane (Fig. 1C).
The diffusion coefficient obtained under such conditions (small
bleach spot) could therefore represent an upper limit of the
mobility experienced by membrane-bound receptors within
domains. We observe that diffusion of serotonin1A-EYFP
receptors monitored with a small bleach spot in cholesterol-
depleted cells is ∼1.5 fold lower than that in normal cells (Fig.
4A and C) thereby indicating that serotonin1A-EYFP receptors
experience a more ordered membrane environment (character-
ized by lower diffusion) upon depletion of cholesterol.
Importantly, since all FRAP experiments were performed on
an arbitrary location on the fluorescent periphery of cells, the
lower diffusion of serotonin1A receptors obtained from FRAP
measurements with a small bleach spot would possibly suggest
that the ordered domains cover a significant fraction of the
cholesterol-depleted cell surface.
3.4. Serotonin1A receptor function in normal and
cholesterol-depleted cells
Cholesterol has been studied quite extensively for its ability
to modulate function of membrane receptors [13,42]. As
discussed above, FRAP analysis with a small bleach spot
indicates that serotonin1A receptors could experience an ordered
membrane environment (characterized by lower lateral diffu-
sion) upon cholesterol depletion. In order to analyze the
functional consequences of such a change in the membrane
environment of serotonin1A receptors in response to cholesterol
depletion, we monitored ligand binding of the serotonin1A
receptor in membranes isolated from cholesterol-depleted cells.
As shown in Fig. 5A, radioligand binding with the specific
agonist [3H]8-OH-DPAT suggests that treatment of intact cells
with increasing concentrations of MβCD (which leads toincreasing extents of cholesterol depletion, see Fig. 2F) leads to
an increase in ligand binding of serotonin1A receptors. For
example, the specific agonist binding is enhanced by ∼51% of
the value in normal cells when cells are treated with 10 mM
MβCD. As a control, we monitored whether cholesterol
depletion of cells expressing the serotonin1A-EYFP receptor,
used in FRAP experiments, displayed a similar effect. Fig. 5A
shows that serotonin1A-EYFP receptors also display an increase
in the specific agonist binding in response to cholesterol
depletion, with a concentration of 10 mM MβCD resulting in a
∼83% increase in binding over that found in normal cells.
Further, saturation binding analysis (see Table 1) shows that
cholesterol depletion with 10 mM MβCD is associated with
∼35% decrease in the equilibrium dissociation constant (Kd)
and ∼16% increase in the maximum number of binding sites
(Bmax) of the agonist to serotonin1A receptors.
Serotonin1A receptor agonists are known to specifically
activate the Gi/Go class of G-proteins in CHO cells thereby
inhibiting cAMP synthesis in cells [43]. This is observed in case
of normal as well as cholesterol-depleted cells as seen by the
progressive decrease in the forskolin-stimulated cAMP levels
with increasing concentrations (10−12 to 10−5 M) of 8-OH-
DPAT (Fig. 5B). Parameters obtained from analysis of the
concentration-dependent inhibition in forskolin-stimulated
cAMP synthesis by the specific agonist 8-OH-DPAT (see
Table 2) show that the half maximal inhibition concentration
(IC50) value for 8-OH-DPAT in normal cells is ∼2.4 nM.
Interestingly, despite the enhanced agonist binding of the
serotonin1A receptor observed for cholesterol-depleted cells
(see Fig. 5A and Table 1), the IC50 value for 8-OH-DPAT in
cholesterol-depleted cells is ∼3 nM, which is similar to that
observed in normal cells. These results show that downstream
signaling of serotonin1A receptors in response to agonist
stimulation remains unaltered upon cholesterol depletion.
Interestingly, the stimulatory effect of forskolin on cAMP
synthesis appears to be different in normal and cholesterol-
depleted cells. Thus, cholesterol-depleted cells generate ∼1.3
fold higher levels of cAMP compared to normal cells in
response to 10 μM forskolin treatment (see Table 2).
The increase in agonist binding (Fig. 5A) of serotonin1A
receptors obtained in membranes isolated from cholesterol-
depleted CHO cells appears inconsistent with our earlier results
where we reported that cholesterol depletion from native hippo-
campal membranes endogenously expressing the serotonin1A
receptor reduces agonist binding and G-protein coupling of the
receptor [22]. A possible reason for such inconsistency could
be that the observed increase in agonist binding to serotonin1A
receptors could be a result of cholesterol depletion of intact
cells in culture and not isolated membranes. To examine this,
we monitored the effect of cholesterol depletion of isolated
cell membranes on the agonist binding to serotonin1A re-
ceptors in such membranes. Fig. 5C shows that treatment of
isolated cell membranes with increasing concentrations of
MβCD in vitro leads to progressive depletion of membrane
cholesterol. Interestingly, cholesterol depletion of isolated cell
membranes does not lead to an increase in the specific [3H]8-
OH-DPAT binding to serotonin1A receptors (Fig. 5D). In fact,
Fig. 5. The specific [3H]8-OH-DPAT binding to serotonin1A (white bars) and serotonin1A-EYFP (gray bars) receptors in membranes isolated from cells treated with
increasing concentrations of MβCD are shown in (A). Data represent the means±S.E. of at least four independent experiments. Inhibition of the forskolin-stimulated
cAMP synthesis mediated by the serotonin1A receptor specific agonist 8-OH-DPAT, monitored in normal (–––○–––) and 10 mM MβCD-treated (
___●___) cells, is
shown in (B). Values are expressed as percentages of cAMP levels in cells exposed to 10 μM forskolin in the absence of 8-OH-DPAT. Data represent the means±S.E.
of at least three independent experiments. The cholesterol contents of isolated cell membranes treated with increasing concentrations of MβCD are shown in (C). Data
represent the means±S.E. of three independent experiments. The specific [3H]8-OH-DPAT binding to cell membranes treated with increasing concentrations of MβCD
is shown in (D). Data represent the means±S.E. of three independent experiments.
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tions of MβCD (leading to increasing extents of cholesterol
depletion) result in a reduction in the specific agonist binding
(Fig. 5D). This result is similar to our previous observations
where depletion of cholesterol from isolated native hippocam-
pal membranes led to a reduction in specific agonist binding
to serotonin1A receptors [22]. Taken together, these results
show that specific agonist binding to serotonin1A receptors is
affected in a remarkably different manner depending onTable 1
Specific [3H]8-OH-DPAT binding parameters of serotonin1A receptors in cell
membranes isolated from normal and cholesterol-depleted cells a
Treatment Kd (nM) Bmax (fmol/mg protein)
Normal cells 0.45±0.11 1278±91
Cholesterol-depleted cells b 0.30±0.08 1481±51
a Binding parameters were calculated by analyzing saturation binding
isotherms with a range (0.1–7.5 nM) of radiolabeled [3H]8-OH-DPAT. Data
represent means±S.E. of three independent experiments. See Materials and
methods for other details.
b Cholesterol depletion was performed on cells in culture using 10 mM
MβCD. See Materials and methods for other details.whether cells in culture (Fig. 5A) or isolated cell membranes
(Fig. 5D) are depleted of cholesterol. Our results show that
cholesterol depletion of metabolically active cells does not lead
to any significant alteration in the cellular distribution of
serotonin1A receptors (see Fig. 2A and B), yet results in an
increase in agonist binding to serotonin1A receptors (Fig. 5A).
A possible reason for this could be a unique alteration in the
membrane environment around the receptor while it is
localized in the plasma membrane, which occurs only uponTable 2
Downstream signaling of serotonin1A receptors in normal and cholesterol-
depleted cells a
Treatment Forskolin stimulation (% of control) IC50 (nM)
Normal cells 384.3±61.9 2.37±0.39
Cholesterol-depleted cells b 500.3±51.4 3.00±0.86
a Downstream signaling of the receptor was assayed by monitoring the
inhibition in forskolin-stimulated cAMP synthesis in cells in presence of a range
(10−12 to 10−5 M) of concentrations of the specific agonist 8-OH-DPAT. The
data represent the means±S.E. of at least three independent experiments. See
Materials and methods and Fig. 5B for other details.
b Cholesterol depletion was performed on cells in culture using 10 mM
MβCD. See Materials and methods for other details.
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cell membranes.
4. Discussion
We have recently analyzed the membrane organization of the
serotonin1A receptor by monitoring its insolubility in non-ionic
detergents utilizing a fluorescence microscopic approach
[44,45]. Resistance to solubilization by mild non-ionic
detergents such as Triton X-100 at low temperatures represents
a widely used biochemical approach to identify, isolate and
characterize lipid-rafts, a class of membrane domains enriched
in cholesterol and sphingolipids [5]. Significantly, such analysis
has indicated that the serotonin1A receptor expressed in CHO
cells is predominantly detergent-soluble. While detergent
insolubility generally represents the first step in characterizing
membrane domains and localization of membrane constituents
such as receptors into these domains, concerns associated with
such methodologies are the use of low temperatures and the
membrane perturbing nature of detergents [46]. In such a
scenario, an alternate approach to critically examine the
organization of the serotonin1A receptor in an unperturbed
cellular environment assumes significance. FRAP measure-
ments performed at variable bleach spot sizes on the serotonin1A
receptor in the plasma membrane constitutes one such
approach. Results from these measurements in normal cells
show nearly constant lateral diffusion parameters with variable
bleach spot size thereby indicating that serotonin1A receptors
experience a homogenous membrane environment at the
spatiotemporal resolution of FRAP measurements. Interest-
ingly, a similar analysis performed on the G-protein coupled
neurokinin 2 (NK2) receptor expressed in HEK293 cells has
previously shown that it experiences confinement in large scale
domains in the plasma membrane [35]. The intrinsic differences
in the membrane organization of different members of the
GPCR family and/or in different cell types could account for
this observation. In addition, dynamic confinement observed in
case of the NK2 receptors in cells could be due to the low
(20 °C) temperature at which cells were maintained to minimize
alterations in the cellular distribution of the receptor in response
to stimuli. The low temperature could induce alterations in the
membrane structure and/or stabilize interactions between the
receptor and cytoskeletal elements underlying the plasma
membrane thereby leading to confinement of the receptor in
the membrane. This points the need for a comprehensive
analysis on multiple GPCRs before attempting to generalize
dynamic behavior of GPCRs in living cells. On a broader
perspective, these studies emphasize the potential of the FRAP
approach performed with variable bleach spot sizes to monitor
the organization of membrane constituents in an intact cellular
environment.
Cholesterol is proposed to maintain a laterally heterogeneous
distribution of lipids and proteins on the plasma membrane due
to its putative role in the formation and maintenance of
membrane domains [2,3]. Recent observations from a variety of
biophysical techniques that monitor membrane dynamics and/or
distribution of membrane components on a scale far lower thanthe resolution of visible light microscopy have indicated the
presence of small and dynamic lipid-based heterogeneities in
cell membranes which are sensitive to perturbation in the
cholesterol and sphingolipid content [47]. Since cholesterol is
believed to be the principal constituent of these domains, its
removal from cell membranes is reported to disrupt the integrity
of these domains [5,6], and therefore represents a widely used
strategy to disrupt putative functions mediated by lipid rafts.
Our results indicate that cholesterol depletion induces
dynamic confinement of serotonin1A receptors in the plasma
membrane based on FRAP experiments with variable bleach
spot sizes. Importantly, since the area monitored in FRAP
experiments is large (in the order of micrometers), these results
suggest a large scale domain organization of the G-protein
coupled serotonin1A receptor induced upon depletion of
cholesterol from the plasma membrane. The possible mechan-
isms leading to the reorganization of the plasma membrane
resulting in dynamic confinement of the serotonin1A receptor
requires further investigation. Interestingly, results from
experiments involving cholesterol depletion from model
membranes with lipid compositions similar to the plasma
membrane, or from the plasma membrane of living cells have
previously suggested large scale domain segregation. The role
of cholesterol on the segregation of lipid phases has recently
been discussed [48]. Thus, in a ternary mixture of saturated
phospholipids or sphingolipids with high melting temperatures
(Tm), unsaturated phospholipids with low Tm, and cholesterol at
30–50 mol%, increasing extents of cholesterol depletion has
been proposed to first lead to the formation of co-existing
liquid-ordered (Lo) and liquid-disordered (Ld) phases followed
by the co-existence of solid gel-like and Ld phases [48].
Importantly, depletion of cholesterol using β-cyclodextrin from
such membranes has been shown to induce segregation of
membrane constituents into large domains that can be
visualized by fluorescence microscopy [49]. Due to the
diversity in lipid composition and the presence of membrane
proteins in natural membranes, a challenging question is
whether similar phase segregation occurs in response to
cholesterol depletion in these membranes. Interestingly, con-
focal microscopic studies of CHO cells, which have a plasma
membrane lipid composition of cholesterol:sphingomyelin:
phospholipid of ∼40:10:50 (mol%) [50], labeled with mem-
brane phase-specific lipid probes, have indicated a large scale
segregation of these probes in the plasma membrane [51].
Furthermore, a comparative analysis of the diffusion behavior
of several membrane constituents and the influence of
temperature on such behavior in normal and cholesterol-
depleted CHO cells have suggested the possibility of formation
of solid-ordered membrane phases in cholesterol depleted cells
[52]. In addition, cholesterol depletion has been reported to alter
the global organization of the cytoskeleton underlying the
plasma membrane that is correlated with alterations in the
content and distribution of phosphatidylinositol 4,5-bispho-
sphate (PI(4,5)P2), an organizer of the actin cytoskeleton, in the
plasma membrane [53]. It is possible that the removal of
cholesterol induces a similar alteration in the distribution of
membrane constituents and/or the organization of the cytoske-
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receptors into domains which were not present on the plasma
membrane prior to cholesterol depletion.
The cell surface organization of membrane constituents in
relation to their partitioning into cholesterol and sphingolipid
enriched domains and/or being confined by the actin cytoske-
leton has recently been monitored based on a novel fluorescence
correlation spectroscopy (FCS) approach [54]. This study
constitutes a systematic analysis of the diffusion time of
fluorescent molecules as a function of the observation area in
FCS, and is based on the principle of FRAP performed at
variable bleach spot sizes [32]. Importantly, such analysis has
suggested that transmembrane proteins display characteristics
of dynamic confinement in native cell membranes which are
relieved upon reducing cellular cholesterol levels and destabi-
lizing the actin cytoskeleton. Although a similar FCS analysis
has not been performed with the serotonin1A receptor, a possible
reason for the apparent discrepancy between the FCS-based
approach and our results could be due to the significantly
smaller observation area monitored on the cell membrane with
the FCS-based approach (range of observation radii ω=∼0.2–
0.4 μm [54]) compared to the present FRAP approach (range of
bleach spot radii ω=1.47–3 μm). As mentioned earlier,
observations from a variety of biophysical techniques that
monitor dynamics and/or distribution of membrane components
on a scale far lower than the resolution of visible light
microscopy have indicated the presence of small and dynamic
lipid-based heterogeneities in cell membranes which are
sensitive to perturbation in the cholesterol and sphingolipid
content [47]. It is therefore possible that the dynamic
confinement of membrane proteins in native membranes and
the escape from confinement by cholesterol depletion and actin
destabilization observed by FCS could be due to the high
spatiotemporal resolution of these measurements. Nevertheless,Fig. 6. A model depicting the possible organization of the serotonin1A-EYFP receptor
serotonin1A-EYFP receptors (black dots) in the plasma membrane of normal cells is
based on the relatively constant diffusion coefficient and mobile fraction of receptors
dynamic confinement of receptors into domains (dark gray circles) on the plasma mem
receptor on the bleach spot size. The distribution of receptors has been depicted to be s
reorganization of the receptor on the cell surface in response to cholesterol depletion (
small bleach spot provide information on the diffusion properties of molecules on a r
receptors in the plasma membrane of cholesterol-depleted cells determined from FRA
serotonin1A-EYFP receptor (gray circles) represent a relatively ordered environme
performed on an arbitrary location on the fluorescent periphery of cells, lower diffusi
size would possibly suggest that the ordered domains could cover a significant fra
domains are not drawn to scale. See text for further details.since FRAP measurements typically monitor diffusion char-
acteristics of molecules on a lower spatiotemporal resolution,
any alteration detected in such characteristics can be assumed to
reflect a more global (large scale) reorganization of the cell
membrane. Based on this rationale, we believe that the
consequences of cholesterol depletion could extend beyond its
putative effects of disrupting cholesterol- and sphingolipid-rich
lipid domains.
It should be noted that FRAPmeasurements performedwith a
small bleach spot on a domainized membrane (Fig. 1C) would
provide information on the lateral diffusion characteristics of
molecules on a relatively local scale (within domains). We
observe that diffusion of serotonin1A receptors monitored with a
small bleach spot in cholesterol-depleted cells is lower than that
in normal cells possibly indicating that serotonin1A receptors
experience a more ordered membrane environment (character-
ized by lower diffusion) upon depletion of cholesterol. Based on
our results, we propose a possible model (see Fig. 6) describing
dynamic confinement of serotonin1A receptors into ordered
domains on the plasma membrane induced upon cholesterol
depletion. Importantly, this model is supported by previous
analysis based on non-ionic detergent insolubility of serotonin1A
receptors which suggested that cholesterol depletion led to a
possible reorganization of the receptor into domains that could
represent an ordered membrane phase [45]. This proposal was
based on the observation that serotonin1A receptors exhibit a
higher degree of detergent insolubility in cholesterol-depleted
cells [45], and on previous literature where the presence of long
chain saturated lipids (that would form an ordered membrane
environment) could confer detergent insolubility to membrane
constituents in the absence of cholesterol [55–57].
From a lipid–protein interaction perspective, the effect of
cholesterol on ligand binding of a variety of G-protein coupled
receptors, including the serotonin1A receptor, is well establishedin the plasma membrane induced upon cholesterol depletion. The distribution of
found to be homogenous at the spatiotemporal resolution of FRAP experiments
with increasing bleach spot size (Fig. 4). Cholesterol depletion of cells leads to
brane resulting in dependence of diffusion coefficient and mobile fraction of the
imilar in normal and cholesterol-depleted cells due to the absence of any obvious
Fig. 2A and B). FRAP experiments performed on a domainized membrane with a
elatively local scale (within domains). The lower mobility of serotonin1A-EYFP
P experiments with a small bleach spot indicates that the domains that confine the
nt than other regions of the same membrane. Since FRAP experiments were
on of the receptors obtained from FRAP measurements with a small bleach spot
ction of the cholesterol-depleted cell surface. Objects depicting receptors and
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the serotonin1A receptor upon depleting cholesterol from cells in
culture. Interestingly, similar experiments carried out when
isolated cell membranes are depleted of cholesterol do not show
such an increase. At the moment, the reasons for such
differences on ligand binding to serotonin1A receptors in
response to cholesterol depletion can only be speculative. We
observe from FRAP experiments, where the area monitored is
large (in the order of micrometers), that cholesterol depletion of
cells leads to confinement of serotonin1A receptors. Such large
scale reorganization appears plausible in membranes that are
spatially continuous over such scales and coupled to the
cytoskeleton (as in the case of intact cells and not in isolated cell
membranes). It is possible that such reorganization due to
cholesterol depletion of living cells could alter the immediate
membrane environment around the receptor in a manner
different from that when isolated cell membranes are depleted
of cholesterol. An altered membrane environment around the
serotonin1A receptor (possibly more ordered based on results
from FRAP experiments with a small bleach spot size, see
above) created as a result of cholesterol depletion of intact cells
could explain the enhanced agonist binding of the receptor
when cells are depleted of cholesterol. It is worthwhile to
mention here that previous experiments to solubilize the
serotonin1A receptor using detergents such as 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propanesulfonate (CHAPS) and
3-[(cholamidopropyl)dimethylammonio]-2-hydroxy-1-propa-
nesulfonate (CHAPSO) have showed that efficient solubiliza-
tion (as shown by increased ligand binding) of functionally
active serotonin1A receptors correlated with the solubilization of
lipids with a markedly higher presence of saturated fatty acyl
chains [58,59]. Interestingly, such solubilization is accompanied
by depletion of membrane cholesterol [60]. Taken together,
these results indicate that an ordered membrane environment
(characterized by enrichment in lipids with saturated fatty acyl
chains) and lacking cholesterol could contribute to enhanced
ligand binding of the serotonin1A receptor.
We extended our analysis of the role of cholesterol in the
function of serotonin1A receptors by monitoring the effects of
cholesterol depletion on its downstream signaling in cells.
Interestingly, the function of molecules involved in GPCR
signaling such as G-proteins and adenylyl cyclase, have earlier
been found to be dependent on the membrane cholesterol
content. A reduction in the cholesterol content has previously
been shown to reduce the intrinsic GTPase activity of Gαi
proteins [61]. Moreover, adenylyl cyclase has been found to
display enhanced activity in cholesterol-depleted cardiomyo-
cytes [62], a result similar to what we observe [see Fig. 5D).
Thus, interpretations on the specific role of cholesterol in
signaling functions of serotonin1A receptors could be compli-
cated by the distinct effects of cholesterol depletion on the
function of other partners in GPCR signal transduction. Our
results show that downstream signaling of serotonin1A receptors
upon stimulation with the agonist remains largely unaltered in
cholesterol-depleted cells despite the effects of cholesterol
depletion on membrane organization and agonist binding to
serotonin1A receptors. A possible reason for this could be theinduction of multiple cellular responses that independently
modulate cAMP levels in cells. Thus, the effect of an increase in
agonist binding of serotonin1A receptors due to cholesterol
depletion could be effectively diminished by the concomitant
increase in cAMP levels by receptor-independent pathway in
cells thereby leading to no apparent change in the concentra-
tion-dependent inhibition of cAMP levels upon stimulation of
the serotonin1A receptor with the agonist in normal and
cholesterol-depleted cells.
Our results indicate that a reduction in membrane cholesterol
content can induce significant changes in the plasma membrane
organization of the serotonin1A receptor. Whether such an
alteration in membrane cholesterol content is physiologically
relevant represents an important question. Previous literature
suggests that chronic administration of cholesterol-lowering
drugs like statins results in the specific reduction of neuronal
membrane cholesterol levels in vivo, leaving serum cholesterol
levels unaffected [63]. Importantly, low serum cholesterol
concentration has been correlated with an increase in the
prevalence of suicide in humans [64], and is partly attributed to
an altered serotonin metabolism [65]. Our present results on the
effect of a reduction in membrane cholesterol levels on the
organization and function of the serotonin1A receptor could
therefore provide an explanation behind the etiology of
psychological disorders that are correlated with an altered
cholesterol metabolism. We are currently exploring the
consequences of statin-induced reduction in membrane choles-
terol levels on the organization and function of the serotonin1A
receptor. Our preliminary results suggest that even modest
levels of cholesterol reduction achieved using statins can induce
significant alterations in the membrane organization and
function of the serotonin1A receptor [T.J. Pucadyil, S.
Shrivastava, S. Ganguly, and A. Chattopadhyay, unpublished
results].
In summary, our results show that cholesterol has an
important role in the global membrane organization and
function of the serotonin1A receptor. These results constitute
the first report on the membrane organization of the serotonin1A
receptor in the plasma membrane of living cells monitored by a
non-perturbing fluorescence-based approach. On a broader
perspective, our results assume significance in understanding
the modulatory role of the membrane lipid environment on the
organization and function of other G-protein coupled trans-
membrane receptors.
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